Results 251 to 260 of about 1,321,168 (316)

UBE2O Drives Immune Evasion and Radioimmunotherapy Resistance in Lung Cancer by Degrading CDKL1 to Induce PD‐L1 Transcription

open access: yesAdvanced Science, EarlyView.
UBE2O targets CDKL1 for the degradation to upregulate PD‐L1 expression and promotes resistance to radioimmunotherapy in lung cancer, supporting the potential of targeting UBE2O as a promising therapeutic strategy. ABSTRACT Resistance to radioimmunotherapy is one of the primary causes of treatment failure in lung cancer patients; however, the underlying
Huichan Xue   +6 more
wiley   +1 more source

Correction: Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys

open access: yesHarm Reduction Journal
Mahkameh Rafiee   +7 more
doaj   +1 more source

Quality and patient safety surveillance systems in healthcare settings: a rapid realist review. [PDF]

open access: yesBMJ Open
Ertuğrul B   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy